Skin Neoplasm: Clinical Trials

2 trials for Skin Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 21Completed 1

Follow Skin Neoplasm: new trials by email Literature Review of Skin Neoplasm trials Research Report on Skin Neoplasm

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients
131I-Tenatumomab - Breast Neoplasm, Head and Neck Neoplasm
Phase 1Terminatedsigma-tau i.f.r. S.p.A.22015-11-012018-09-18
A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma
ASN-002, 5-FU - Basal Cell Nevus Syndrome, Skin Neoplasm
Phase 1 / Phase 2CompletedAscend Biopharmaceuticals Ltd162015-09-012018-06-06

Narrower conditions

Skin Neoplasms (2)  ·  Basal Cell Nevus Syndrome (1)  ·  Breast Neoplasms (1)  ·  Digestive System Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Pancreatic Neoplasms (1)  ·  Respiratory Tract Neoplasms (1)  ·  Urogenital Neoplasms (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Abnormalities, Multiple (1)  ·  Bone Cysts (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Developmental (1)  ·  Breast Diseases (1)  ·  Carcinoma (1)  ·  Carcinoma, Basal Cell (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Cysts (1)

Interventions

Fluorouracil (1)  ·  gusacitinib (1)

Sponsors

Ascend Biopharmaceuticals Ltd (1)  ·  sigma-tau i.f.r. S.p.A. (1)

Countries

Australia (1)  ·  France (1)  ·  Italy (1)

Top investigators

Gregory Siller (1)  ·  Lynda Spelman (1)  ·  Rodney Sinclair (1)

NIH funding

2014 (1)